Oncology Institute PE Ratio 2020-2024 | TOI
Current and historical p/e ratio for Oncology Institute (TOI) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Oncology Institute PE ratio as of April 30, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Oncology Institute PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-04-30 | 2.48 | 0.00 | |
| 2024-12-31 | 0.31 | $-0.71 | 0.00 |
| 2024-09-30 | 0.33 | $-0.78 | 0.00 |
| 2024-06-30 | 0.46 | $-0.79 | 0.00 |
| 2024-03-31 | 1.58 | $-0.81 | 0.00 |
| 2023-12-31 | 2.04 | $-0.92 | 0.00 |
| 2023-09-30 | 1.40 | $-0.86 | 0.00 |
| 2023-06-30 | 0.55 | $-0.84 | 0.00 |
| 2023-03-31 | 0.68 | $-0.71 | 0.00 |
| 2022-12-31 | 1.65 | $-0.17 | 0.00 |
| 2022-09-30 | 4.63 | $-0.17 | 0.00 |
| 2022-06-30 | 5.06 | 0 | 0.00 |
| 2022-03-31 | 7.13 | $0.06 | 118.83 |
| 2021-12-31 | 9.75 | $-0.15 | 0.00 |
| 2021-09-30 | 9.94 | 0 | 0.00 |
| 2021-06-30 | 9.95 | 0 | 0.00 |
| 2021-03-31 | 9.96 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.189B | $0.393B |
| The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.368B | 26.70 |
| Elevance Health (ELV) | United States | $93.458B | 12.06 |
| CVS Health (CVS) | United States | $81.990B | 12.00 |
| Cencora (COR) | United States | $56.269B | 20.42 |
| Natera (NTRA) | United States | $20.939B | 0.00 |
| DiDi Global (DIDIY) | China | $20.365B | 29.93 |
| BioMerieux (BMXMF) | France | $15.507B | 0.00 |
| ICON (ICLR) | Ireland | $12.058B | 10.95 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.881B | 0.00 |
| Solventum (SOLV) | United States | $11.461B | 10.69 |
| CochLear (CHEOY) | Australia | $11.380B | 0.00 |
| Revvity (RVTY) | United States | $11.373B | 19.20 |
| Doximity (DOCS) | United States | $10.781B | 56.07 |
| Viatris (VTRS) | United States | $9.955B | 3.15 |
| Medpace Holdings (MEDP) | United States | $8.805B | 23.39 |
| Avantor (AVTR) | United States | $8.647B | 12.56 |
| Sonic Healthcare (SKHHY) | Australia | $8.152B | 0.00 |
| HealthEquity (HQY) | United States | $7.475B | 36.77 |
| Charles River Laboratories (CRL) | United States | $5.761B | 11.36 |
| Bausch + Lomb (BLCO) | Canada | $4.848B | 22.13 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Alignment Healthcare (ALHC) | United States | $3.446B | 0.00 |
| Organon (OGN) | United States | $3.421B | 3.45 |
| GeneDx Holdings (WGS) | United States | $3.283B | 389.90 |
| Sotera Health (SHC) | United States | $3.210B | 18.54 |
| BrightSpring Health Services (BTSG) | United States | $3.069B | 31.87 |
| Surgery Partners (SGRY) | United States | $2.863B | 32.84 |
| Concentras Parent (CON) | United States | $2.815B | 14.64 |
| Progyny (PGNY) | United States | $1.967B | 43.32 |
| Premier (PINC) | United States | $1.862B | 11.92 |
| Ardent Health Partners (ARDT) | United States | $1.806B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.788B | 38.83 |
| Agilon Health (AGL) | United States | $1.569B | 0.00 |
| PACS (PACS) | United States | $1.486B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.285B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.078B | 9.04 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| CareDx (CDNA) | United States | $1.008B | 17.10 |
| Establishment Labs Holdings (ESTA) | $0.873B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.770B | 6.09 |
| Embecta (EMBC) | United States | $0.730B | 5.00 |
| Nutex Health (NUTX) | United States | $0.579B | 11.35 |
| QDM (QDMI) | Hong Kong, SAR China | $0.554B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.530B | 14.04 |
| Sonida Senior Living (SNDA) | United States | $0.444B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.402B | 37.90 |
| LifeMD (LFMD) | United States | $0.384B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.349B | 0.00 |
| SBC Medicals (SBC) | United States | $0.347B | 0.00 |
| DocGo (DCGO) | United States | $0.233B | 9.50 |
| Performant Healthcare (PHLT) | United States | $0.184B | 0.00 |
| Beauty Health (SKIN) | United States | $0.125B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| OncoCyte (OCX) | United States | $0.089B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.084B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Biodesix (BDSX) | United States | $0.078B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.057B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.021B | 0.00 |
| ModivCare (MODV) | United States | $0.018B | 6.32 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |